伴侣辅助认知行为治疗失眠与认知行为治疗失眠:一项随机对照试验
本研究为混合效应随机实效性试验,纳入120名失眠来访者,随机等分至伴侣辅助认知行为治疗失眠(PA-CBTI)、传统个体认知行为治疗失眠(i-CBTI)或伴侣辅助睡眠管理治疗(PA-SMT,对照组),所有干预均为每周1次、每次1小时、共7次。主要评估临床医生评定的治疗依从性及基于日记的刺激控制与睡眠限制依从性,并在治疗前、治疗后及6个月随访时评估。
要点
- 伴侣辅助CBTI旨在通过纳入床伴提高治疗依从性和完成率。
- 所有干预均为每周1次1小时、共7次,随访至6个月。
核心结论
- 这是首个考察将床伴纳入失眠治疗的随机临床试验,结果将为伴侣在失眠表现和治疗反应中的作用提供新信息,并更好界定依从性在CBTI中的作用。
研究设计与样本
- 混合效应随机实效性试验,纳入120名失眠来访者,随机等分至PA-CBTI、i-CBTI或PA-SMT(对照组)。
- 所有干预均为每周1次、每次1小时、共7次;来访者与伴侣在治疗前、治疗后及6个月随访时完成主要评估。
主要发现
- 原文未报告结果。
关键数值与推荐
- 主要结局为临床医生评定的治疗依从性及基于日记的刺激控制与睡眠限制依从性。
- 次要结局包括体动记录仪、睡眠相关自评量表、共病精神病理及关系功能。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Insomnia is a prevalent sleep disorder associated with significant economic and personal burdens. Cognitive behavioural therapy for insomnia (CBTI) is considered the gold standard intervention for insomnia and its efficacy has been well demonstrated. However, the core treatment strategies of CBTI require significant behavioural change, which many individuals find challenging. As a result, although CBTI is efficacious, its effectiveness is reduced by modest levels of adherence in typical clinical settings. This is problematic as adherence is essential to attain desired treatment outcomes. Sleep is often a dyadic process, with approximately 60% of Australian adults sharing a bed. Hence, the present study aims to determine whether incorporating bed partners into treatment for insomnia increases treatment adherence and completion. The impact of adherence on symptoms of insomnia will also be examined. METHODS: This study is a mixed-effects randomised effectiveness trial of partner-assisted CBTI (PA-CBTI). It is an "effectiveness" (as opposed to "efficacy") trial, due to the focus on "real world" clinic-based clients and adherence/attrition as outcomes. Participants will include 120 clients with insomnia who are randomly assigned, in equal numbers, to PA-CBTI, traditional individual CBTI (i-CBTI), or partner-assisted sleep management therapy (PA-SMT; which serves as the control group). All interventions consist of seven weekly 1-h sessions. Treatment outcome is evaluated using clinician-rated treatment adherence, and diary-based adherence to stimulus control and sleep restriction. Clients and partners complete major assessments at pre- and post-treatment, and at 6-month follow-up. Secondary outcome variables include actigraphy, self-report measures related to sleep, comorbid psychopathology, and relationship functioning. DISCUSSION: This is the first randomised clinical trial to examine the impact of incorporating the bed partner in the treatment of insomnia. Results will provide new information about the role partners play in clients' insomnia presentation and treatment response, and better define the role of adherence in CBTI. This trial has the potential to optimise treatment outcomes for insomnia by improving adherence and reducing attrition. Results could have far-reaching impacts. Improvements in insomnia have been linked to improvements in mental and physical health and, given the high financial costs of insomnia, this study could have a positive economic impact. TRIAL REGISTRATION: ACTRN, ACTRN12616000586415 . Registered on 5 May 2016.
引用
- Mellor A, Hamill K, Jenkins MM, et al. Partner-assisted cognitive behavioural therapy for insomnia versus cognitive behavioural therapy for insomnia: a randomised controlled trial. Trials. 2019. PMID: 31068225. doi:10.1186/s13063-019-3334-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。